Millions of drug alerts may be misleading: massive study to find out which QT drugs actually harm hearts

NCT ID NCT07374263

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether certain medications known to affect the heart's electrical activity (QT-prolonging drugs) actually cause major heart problems in hospitalized adults. Researchers will analyze data from over 990,000 patients across Ontario hospitals, comparing those who had heart events to those who did not. The goal is to improve medication safety and reduce unnecessary warnings that can overwhelm healthcare workers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could clarify which QT-prolonging drugs truly pose heart risks, reducing unnecessary medication alerts and improving patient safety.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED LONG QT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • GEMINI

    RECRUITING

    Toronto, Ontario, M5B 1T8, Canada

  • St. Joseph's Healthcare Hamilton

    RECRUITING

    Hamilton, Ontario, L8N 1Y3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.